Therefore, our aim was to evaluate the relevance of hyperpolarized (HP) 13C-pyruvate and 13C-MRS fluxomic after U-13C-glucose injection as early-response markers to anti-PD1 therapy in syngeneic melanoma xenografts. Here, PDCD1 is linked to melanoma.